TEMPE, Ariz. — More than two years into a global pandemic, the clear need for innovative medical breakthroughs has never been more obvious. The Mayo Clinic and Arizona State University (ASU) MedTech Accelerator, a flagship program of the Mayo Clinic and ASU Alliance for Health Care, was designed to help empower medical startups to better navigate challenges while bringing forth life-changing health innovations. The third cohort of this program launched on March 28.Continue reading
Author Archive: AZBio
HB2039 Health; Innovation; Trust Fund
On March 29, 2022, Arizona’s Senate Appropriations Committee voted unanimously to give a Do Pass as Amended recommendation for HB2039. The next step in the process is review by the Senate Rules Committee.
If HB2039 successfully completes the legislative process and is signed into law by the Governor, it will establish the statutory framework for the Arizona Health Innovation Trust Fund within the Arizona State Treasurer’s Office with the State Treasurer as Trustee. Continue reading
Making Our Way to Top-10 Bioscience Status
Arizona is not a top-10 bioscience state yet but were making the right moves and pursuing the goal. Check out some of the key programs and initiatives that will get us there.Continue reading
Phoenix Expands the Bio Research Campus Brand; Welcome the ‘Phoenix Bioscience Core’
Health-advancing discoveries underway in Phoenix show promise that the cure for cancers comes through the city’s biosciences ecosystem.
Life365 Partners with Microsoft Cloud for Healthcare to Empower Providers and Payors to Transition Care to Low-Cost Settings – Home
Scottsdale, AZ, March 22, 2022— Life365, a Microsoft Partner and leading Virtual Care and Remote Patient Monitoring (RPM) platform, announced today the integration into Microsoft Cloud for Healthcare, empowering Providers and Payors to connect and scale to larger patient populations in low-cost settings, typically at home.Continue reading
Are You Ready for the Rise in Virtual Care (Guest Post by LIFE365)
The rise in virtual care has opened the door for healthcare delivery transformation. This rise can be linked back to the pandemic, and new reimbursement opportunities for remote care services, which have fueled the adoption of digital health technologies, including remote patient monitoring.Continue reading
HTG Molecular Diagnostics Announces $7.5 Million Private Placement
TUCSON, Ariz., March 18, 2022 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has entered into a definitive securities purchase agreement to sell securities in a private placement with a leading healthcare investor. The gross proceeds to HTG from the private placement, before deducting the placement agent fees and other estimated fees and expenses related to the private placement, are expected to be approximately $7.5 million. HTG intends to use the net proceeds from the private placement for working capital and general corporate purposes.
Nearly 100 Organizations and Experts Urge HHS Secretary Xavier Becerra to Reject Xtandi March-In Petition
WASHINGTON, D.C. (March 17) — In a letter transmitted today, the Bayh-Dole Coalition and nearly 100 prominent academic and private sector innovation experts and organizations, public policy associations, and legal scholars urged U.S. Department of Health and Human Services Secretary Xavier Becerra to reject the latest march-in petition on prostate cancer drug Xtandi.Continue reading
Ivy Brain Tumor Center Opens New Clinical Trial for Patients with Recurrent Grade IV Gliomas
Study offers therapeutic expansion phase for patients with a positive pharmacokinetic response to investigational drug
UArizona engineer leads $1M project to fight vision loss
Biomedical engineering and optical sciences professor DK Kang is developing a way to diagnose and treat corneal ulcers that’s eight times cheaper and 20 times faster than today’s gold standard.Continue reading